Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
24 November 2023 | Story Valentino Ndaba | Photo SUPPLIED
UFS KovsieCare GBV Social Media
The UFS is joining forces with the international community during the annual 16 Days of Activism against Gender-Based Violence.

As the world will soon commemorate the 16 Days of Activism against Gender-Based Violence (GBV) campaign, the University of the Free State (UFS) joins the fight against this pervasive issue. Dedicated to eradicating GBV and fostering a safe environment, the institution has pledged an unwavering commitment to a zero-tolerance stance against all forms of GBV.

The 16 Days of Activism against Gender-Based Violence is an annual global initiative that starts on 25 November 2023 – International Day for the Elimination of Violence against Women – and concludes on 10 December 2023 – Human Rights Day. The theme for this year, ‘Accelerating actions to end gender-based violence and femicide: leaving no one behind’, emphasises the need for a comprehensive, inclusive effort to combat GBV. 

Legislation addressing GBV

Gender-based violence, rooted in the systemic imbalance of power and authority, manifests in multifaceted forms that encompass emotional, physical, financial, and sexual abuse, among others. Recognising the gravity of this issue, parliament has enacted laws, including the Domestic Violence Act of 1998 and the Children's Act of 2005, striving to safeguard individuals from such atrocities and championing fundamental human rights.

The UFS, aligned with parliament's vision and encapsulating its own Vision 130 within the 2023-2028 Strategic Plan, remains steadfast in its dedication to fostering a culture of accountability, care, and social justice within its staff and student community. 

The significance of activism

Dr Lentsu Nchabeleng, Deputy Director in the Gender Equality and Anti-Discrimination Office (GEADO), emphasised the pivotal role of the 16 Days of Activism in societal progress. “Advocacy plays an important role in prevention by promoting education and awareness. Advocacy challenges harmful societal norms and stereotypes that contribute to gender-based violence and can help foster a culture of equality and respect," she stated.

Useful resources

The UFS has provided resources for the staff and student community, including frequently asked questions (FAQs) about GBV and sexual offences, aiming to clarify these important matters. Help and reporting avenues for GBV and sexual misconduct are available on the Bloemfontein and South campuses, with similar support available on the Qwaqwa Campus, underscoring the university's dedication to a safe and supportive environment for all. 

Click to download the resource documents:

Important contacts 

The university has also implemented support systems, including dedicated 24-hour toll-free helplines for reporting GBV and sexual offenses, underscoring its commitment to addressing this epidemic.

  • GEADO toll-free: 0800 204 682
  • UFS Student Careline toll-free: 0800 00 6363

 

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept